South & Central America Parenteral Nutrition Market Forecast to 2030 - Regional Analysis

Description

List of Tables

The South & Central America parenteral nutrition market was valued at US$ 360.63 million in 2022 and is expected to reach US$ 597.42 million by 2030; it is estimated to record a CAGR of 6.5% from 2022 to 2030.

Improved Healthcare Infrastructure Fuels South & Central America Parenteral Nutrition Market

With over 19,000 hospitals in the region, Latin America provides a wide range of healthcare options. As of 2023, there will be 6,642 more hospitals in Brazil than there are in the US. Investments in healthcare infrastructure and the expansion of healthcare facilities in the South & Central America region present opportunities for the development and distribution of parenteral nutrition products and services.

Additionally, malnutrition affects 74% of severely ill hospitalized patients in Latin America. In order to fight patient malnutrition in Latin America and around the world, Fresenius Kabi is dedicated to advancing research and providing funds. Under the 'United for Clinical Nutrition' project, which aims to strengthen clinical research in Latin America, the company has provided research grants totaling US$ 106,630 (100,000) since 2018.

In 2023, Healthcare practitioners applied for the third Parenteral Nutrition Research Grant Latin America to fund clinical nutrition research initiatives. The award is valid for two years. It seeks to support serious research in parenteral nutrition therapy, help solve the problem of malnourished critically ill patients in Latin America and provide funds to support additional research that will support appropriate parenteral nutrition.

South & Central America Parenteral Nutrition Market Overview

The incidence of neurological disorders has been correlated with the aging population in Brazil. According to the World Health Organization and the Brazilian Institute of Geography and Statistics, by 2040, the geriatric population in Brazil (aged above 60 years) will reach ~55 million. In the coming years, the rising geriatric population is anticipated to increase the incidence of chronic neurological disorders, which is likely to propel the demand for parenteral nutrition. Thus, the growing incidence of diabetes, cancer, and other chronic diseases drives the parenteral nutrition market in Brazil. This factor is likely to increase the demand for parenteral nutrition in treating patients.

South & Central America Parenteral Nutrition Market Revenue and Forecast to 2030 (US$ Million)

South & Central America Parenteral Nutrition Market Segmentation

The South & Central America parenteral nutrition market is segmented based on nutrient type, end user, and country. Based on nutrient type, the South & Central America parenteral nutrition market is categorized into single dose amino acid solution, parenteral lipid emulsion, carbohydrates, trace elements, and vitamins and minerals. The single dose amino acid solution segment held the largest market share in 2022.

By end user, the South & Central America parenteral nutrition market is segmented into hospitals, clinics, and others. The hospitals segment held the largest market share in 2022.

Based on country, the South & Central America parenteral nutrition market is segmented into Brazil, Argentina, and the Rest of South & Central America. Brazil dominated the South & Central America parenteral nutrition market share in 2022.

ICU Medical Inc, Grifols SA, Pfizer Inc, Otsuka Pharmaceuticals Co Ltd, Baxter International Inc, B Braun SE, Fresenius Kabi AG, Aculife Healthcare Pvt Ltd, and Vifor Pharma Management AG are some of the leading players operating in the South & Central America parenteral nutrition market.

Product Code: BMIRE00030557

1. Introduction

1.1 The Insight Partners Research Report Guidance
1.2 Market Segmentation

2. Executive Summary

2.1 Key Insights

3. Research Methodology

3.1 Coverage
3.2 Secondary Research
3.3 Primary Research

4. South & Central America Parenteral Nutrition Market - Key Industry Dynamics

4.1 Market Drivers
- 4.1.1 Rise in Prevalence of Gastrointestinal Diseases
- 4.1.2 Surge in Cases of Malnutrition and Premature Births
4.2 Market Restraints
- 4.2.1 Mechanical, Gastrointestinal, and Metabolic Complications Associated with Parenteral Feeding Systems
4.3 Market Opportunities
- 4.3.1 Improved Healthcare Infrastructure in South & Central America
4.4 Future Trends
- 4.4.1 Innovation in Formulations of Nutrition Products
4.5 Impact Analysis

5. Parenteral Nutrition Market - South & Central America Market Analysis

5.1 Overview
5.2 Parenteral Nutrition Market Revenue (US$ Mn), 2020 - 2030

6. South & Central America Parenteral Nutrition Market Analysis - by Nutrient Type

6.1 Overview
6.2 Single Dose Amino Acid Solution
- 6.2.1 Overview
- 6.2.2 Single Dose Amino Acid Solution: Parenteral Nutrition Market - Revenue and Forecast to 2030 (US$ Million)
6.3 Parenteral Lipid Emulsion
- 6.3.1 Overview
- 6.3.2 Parenteral Lipid Emulsion: Parenteral Nutrition Market - Revenue and Forecast to 2030 (US$ Million)
6.4 Carbohydrates
- 6.4.1 Overview
- 6.4.2 Carbohydrates: Parenteral Nutrition Market - Revenue and Forecast to 2030 (US$ Million)
6.5 Trace Elements
- 6.5.1 Overview
- 6.5.2 Trace Elements: Parenteral Nutrition Market - Revenue and Forecast to 2030 (US$ Million)
6.6 Vitamins and Minerals
- 6.6.1 Overview
- 6.6.2 Vitamins and Minerals: Parenteral Nutrition Market - Revenue and Forecast to 2030 (US$ Million)

7. South & Central America Parenteral Nutrition Market Analysis - by End User

7.1 Overview
7.2 Hospitals
- 7.2.1 Overview
- 7.2.2 Hospitals: Parenteral Nutrition Market - Revenue and Forecast to 2030 (US$ Million)
7.3 Clinics
- 7.3.1 Overview
- 7.3.2 Clinics: Parenteral Nutrition Market - Revenue and Forecast to 2030 (US$ Million)
7.4 Others
- 7.4.1 Overview
- 7.4.2 Others: Parenteral Nutrition Market - Revenue and Forecast to 2030 (US$ Million)

8. South & Central America Parenteral Nutrition Market - Country Analysis

8.1 South & Central America
- 8.1.1 South & Central America: Parenteral Nutrition Market - Revenue and Forecast Analysis - by Country
  - 8.1.1.1 Brazil: Parenteral Nutrition Market - Revenue and Forecast to 2030 (US$ Million)
    - 8.1.1.1.1 Overview
    - 8.1.1.1.2 Brazil: Parenteral Nutrition Market - Revenue and Forecast to 2030 (US$ Million)
    - 8.1.1.1.3 Brazil: Parenteral Nutrition Market Breakdown, by Nutrient Type
    - 8.1.1.1.4 Brazil: Parenteral Nutrition Market Breakdown, by End User
  - 8.1.1.2 Argentina: Parenteral Nutrition Market - Revenue and Forecast to 2030 (US$ Million)
    - 8.1.1.2.1 Overview
    - 8.1.1.2.2 Argentina: Parenteral Nutrition Market - Revenue and Forecast to 2030 (US$ Million)
    - 8.1.1.2.3 Argentina: Parenteral Nutrition Market Breakdown, by Nutrient Type
    - 8.1.1.2.4 Argentina: Parenteral Nutrition Market Breakdown, by End User
  - 8.1.1.3 Rest of South & Central America: Parenteral Nutrition Market - Revenue and Forecast to 2030 (US$ Million)
    - 8.1.1.3.1 Overview
    - 8.1.1.3.2 Rest of South & Central America: Parenteral Nutrition Market - Revenue and Forecast to 2030 (US$ Million)
    - 8.1.1.3.3 Rest of South & Central America: Parenteral Nutrition Market Breakdown, by Nutrient Type
    - 8.1.1.3.4 Rest of South & Central America: Parenteral Nutrition Market Breakdown, by End User

9. Industry Landscape

9.1 Overview
- 9.1.1 Overview

10. Company Profiles

10.1 ICU Medical Inc
- 10.1.1 Key Facts
- 10.1.2 Business Description
- 10.1.3 Products and Services
- 10.1.4 Financial Overview
- 10.1.5 SWOT Analysis
- 10.1.6 Key Developments
10.2 Grifols SA
- 10.2.1 Key Facts
- 10.2.2 Business Description
- 10.2.3 Products and Services
- 10.2.4 Financial Overview
- 10.2.5 SWOT Analysis
- 10.2.6 Key Developments
10.3 Pfizer Inc
- 10.3.1 Key Facts
- 10.3.2 Business Description
- 10.3.3 Products and Services
- 10.3.4 Financial Overview
- 10.3.5 SWOT Analysis
- 10.3.6 Key Developments
10.4 Otsuka Pharmaceuticals Co Ltd
- 10.4.1 Key Facts
- 10.4.2 Business Description
- 10.4.3 Products and Services
- 10.4.4 Financial Overview
- 10.4.5 SWOT Analysis
- 10.4.6 Key Developments
10.5 Baxter International Inc
- 10.5.1 Key Facts
- 10.5.2 Business Description
- 10.5.3 Products and Services
- 10.5.4 Financial Overview
- 10.5.5 SWOT Analysis
- 10.5.6 Key Developments
10.6 B Braun SE
- 10.6.1 Key Facts
- 10.6.2 Business Description
- 10.6.3 Products and Services
- 10.6.4 Financial Overview
- 10.6.5 SWOT Analysis
- 10.6.6 Key Developments
10.7 Fresenius Kabi AG
- 10.7.1 Key Facts
- 10.7.2 Business Description
- 10.7.3 Products and Services
- 10.7.4 Financial Overview
- 10.7.5 SWOT Analysis
- 10.7.6 Key Developments
10.8 Vifor Pharma Management AG
- 10.8.1 Key Facts
- 10.8.2 Business Description
- 10.8.3 Products and Services
- 10.8.4 Financial Overview
- 10.8.5 SWOT Analysis
- 10.8.6 Key Developments
10.9 Aculife Healthcare Pvt Ltd
- 10.9.1 Key Facts
- 10.9.2 Business Description
- 10.9.3 Products and Services
- 10.9.4 Financial Overview
- 10.9.5 SWOT Analysis
- 10.9.6 Key Developments

11. Appendix

11.1 About The Insight Partners
11.2 Glossary of Terms